QA: Paratek Pharmaceuticals Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178711_2023_Paratek_Pharmaceuticals_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178711, Paratek Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 136,842,000
1 IntangibleAssetsNetIncludingGoodwill 829,000
2 PropertyPlantAndEquipmentNet 616,000
3 remainder_Assets 34,251,000
4 LiabilitiesCurrent 37,388,000
5 LiabilitiesNoncurrent 260,867,000
6 remainder_Liabilities 45,325,000
7 CostOfGoodsAndServicesSold 24,576,437
8 SellingGeneralAndAdministrativeExpense 187,921,666
9 ResearchAndDevelopmentExpense 39,935,395
10 remainder_Expenses 18,349,487
11 remainder_Revenues 197,067,704
12 remainder_NetIncome 659,569
13 remainder_ComprehensiveNetIncome 3,400
  yvar yval
0 Assets 172,538,000
1 Liabilities 343,580,000
2 Expenses 270,782,985
3 Revenues 197,067,704
4 StockholdersEquity -171,042,000
5 NetIncome -73,055,712
6 ComprehensiveNetIncome -73,054,012
7 BaseVar 492,315,829
8 EconomicCapitalRatiobeforeLimitedLiability -1.73
9 EconomicCapitalRatio 1.11

Edgar->Model Mapping

Feature Distribution

Change over Time